Laura Lee Sandler is COO at Oruka Therapeutics, Inc. (ORKA). They have made 4 open-market trades across 1 company since 2026, most recently 2026-09-15.
CIK 0002075401
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ORKA | 235,478 | $17.0M |
Shares reported on the most recent Form 4, priced at the 2026-09-15 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ORKA | SELL | 2026-09-15 | 2026-09-15 | $95.71 | $87K | -9.1% | -20.5% | — |
| ORKA | SELL · 10b5-1 | 2026-07-01 | 2026-07-01 | $94.42 | $472K | -3.6% | +6.5% | -9.5% |
| ORKA | SELL | 2026-06-15 | 2026-06-15 | $69.69 | $42K | +32.0% | +26.3% | +39.8% |
| ORKA | SELL · 10b5-1 | 2026-05-01 | 2026-05-01 | $63.88 | $319K | +2.7% | -10.5% | +59.6% |
| ORKA | SELL | 2026-03-16 | 2026-03-17 | $41.30 | $25K | +7.8% | +62.5% | +67.1% |
| ORKA | SELL · 10b5-1 | 2026-03-02 | 2026-03-02 | $33.56 | $168K | -1.6% | +55.2% | +69.3% |
| ORKA | SELL | 2026-01-02 | 2026-01-02 | $28.52 | $371K | +14.1% | +22.3% | +90.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.